IBRX
#998
ImmunityBio, Inc. - Common Stock
8.4 0 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.82%
Changement Mensuel
+20.00%
Evolution sur 6 mois
-13.13%
Changement Annuel
+258.97%
Clôture Précédente
8.2 5
Open
8.4 0
Low
8.4 0
High
8.4 0
Volume
132
Financials
- Market Capitalization 8.9 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.21
ratio cours/chiffre d'affaires
16.08
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 992 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.85 USD | +0.01% | +0.18% | +1.14% | +106.45% | 9.00 B USD | ||
| 993 |  ABVX Abivax SA - American Depositary Shares | 114.30 USD | -1.91% | -2.88% | -8.49% | +39.39% | 8.98 B USD | ||
| 1019 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.72 USD | +1.25% | +10.08% | +1.55% | +92.01% | 8.53 B USD | ||
| 1032 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.96 USD | +0.01% | +0.11% | +0.60% | +151.84% | 8.39 B USD |